183 days ago • Posted by Charles-Henry Monchau

Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial

Pfizer chief executive Albert Bourla sold 62% of his stock in the company on the same day the drugmaker announced the results of its COVID-19 vaccine trial. Bourla sold $5.6 million in stock on Monday as part of a predetermined trading plan adopted on August 19. His stock sale was carried out at $41.94 a share. The 52-week-high for Pfizer stock is $41.99, which means the CEO cashed out his shares close to their highest this year - source: Markets Insiders

#Stocks
Pfizer CEO
bg_nwsletter